Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    002603   CNE1000015S0

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

(002603)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2023-01-31
30.00 CNY   +3.45%
01/20Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance Catalog
MT
01/08Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Drugs For COVID-19
MT
01/03Gloom and boom: Fund managers' top picks for 2023
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022

08/25/2022 | 04:49am EST

Shijiazhuang Yiling Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 5,566.27 million compared to CNY 5,896.09 million a year ago. Net income was CNY 1,048.57 million compared to CNY 964.12 million a year ago.

Basic earnings per share from continuing operations was CNY 0.6276 compared to CNY 0.5771 a year ago. Diluted earnings per share from continuing operations was CNY 0.6276 compared to CNY 0.5771 a year ago.


ę S&P Capital IQ 2022
All news about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
01/20Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance..
MT
01/08Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Dr..
MT
01/03Gloom and boom: Fund managers' top picks for 2023
RE
2022Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results
MT
2022Health Care Tick Down on Growth Fears -- Health Care Roundup
DJ
2022North American Morning Briefing: China Optimism Gives Bo..
DJ
2022China stocks jump on easing COVID curbs
RE
2022China stocks rise on further eased COVID rules
RE
2022Shijiazhuang Yiling Pharma Secures Regulatory Nod For Traditional Chinese Medicine Tria..
MT
2022Yiling Pharma Denies Claims That COVID-19 Drug May Cause Liver Injury
MT
More news
Financials
Sales 2022 11 204 M 1 662 M 1 662 M
Net income 2022 1 646 M 244 M 244 M
Net cash 2022 9,50 M 1,41 M 1,41 M
P/E ratio 2022 30,5x
Yield 2022 1,25%
Capitalization 50 121 M 7 434 M 7 434 M
EV / Sales 2022 4,47x
EV / Sales 2023 3,76x
Nbr of Employees 15 155
Free-Float 41,0%
Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Duration : Period :
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 30,00 CNY
Average target price 33,05 CNY
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Xiang Jun Wu Director & General Manager-Marketing Center
Chen Guang Li Chief Financial Officer & Director
Yi Ling Wu Chairman
Xue Dong Gao Chairman-Supervisory Board
Zhen Wang Independent Director